Single Technologies

Single Technologies has created 3-D Sequencing, a cube-style DNA sequencing solution that moves beyond traditional flat-surface scaling to three-dimensional architecture. The technology drastically increases the number of DNA sequences that can be read in parallel and naturally unites sequencing with spatial biology. The company's upcoming Theta platform is the world's first 3-D sequencer, enabling massive parallelism in both in situ and solution-based DNA sequencing with unprecedented throughput. The multi-layered structure delivers unparalleled data throughput, and the unique in-cell 3-D sequencing capability allows higher read counts per cell and analysis of more cells in a single run. Single Technologies empowers innovators in gene editing, proteomics, and spatial biology research. Founded in 2012, headquartered in Stockholm, Sweden, The company has raised $7.6M at the Series A stage, backed by investors including KTH Holding, Rothesay, Europa, Almi Invest..